Tian Medical Inc.   Report issue

For profit Phase 4
Founded: Chicago IL United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2012
NCT01709708
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

levobupivacaine (chirocaine) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Migraine Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2